DE69000746D1 - Praeparat zur behandlung von systemischem lupus erythomatosus. - Google Patents

Praeparat zur behandlung von systemischem lupus erythomatosus.

Info

Publication number
DE69000746D1
DE69000746D1 DE9090104128T DE69000746T DE69000746D1 DE 69000746 D1 DE69000746 D1 DE 69000746D1 DE 9090104128 T DE9090104128 T DE 9090104128T DE 69000746 T DE69000746 T DE 69000746T DE 69000746 D1 DE69000746 D1 DE 69000746D1
Authority
DE
Germany
Prior art keywords
preparation
systemic lupus
treating systemic
lupus erythomatosus
erythomatosus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090104128T
Other languages
English (en)
Other versions
DE69000746T2 (de
Inventor
Takeshi Miyata
Kazuo Takahama
Hirofumi Kai
Takayuki Ishii
Kenji Komatsu
Sadanori Ogasawara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KANTO ISHI PHARMA CO Ltd
Mect Corp
Original Assignee
KANTO ISHI PHARMA CO Ltd
Mect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KANTO ISHI PHARMA CO Ltd, Mect Corp filed Critical KANTO ISHI PHARMA CO Ltd
Publication of DE69000746D1 publication Critical patent/DE69000746D1/de
Application granted granted Critical
Publication of DE69000746T2 publication Critical patent/DE69000746T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE9090104128T 1989-03-08 1990-03-02 Praeparat zur behandlung von systemischem lupus erythomatosus. Expired - Fee Related DE69000746T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1055562A JPH02235816A (ja) 1989-03-08 1989-03-08 全身性エリテマトーデス用剤

Publications (2)

Publication Number Publication Date
DE69000746D1 true DE69000746D1 (de) 1993-02-25
DE69000746T2 DE69000746T2 (de) 1993-05-27

Family

ID=13002144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090104128T Expired - Fee Related DE69000746T2 (de) 1989-03-08 1990-03-02 Praeparat zur behandlung von systemischem lupus erythomatosus.

Country Status (8)

Country Link
EP (1) EP0386657B1 (de)
JP (1) JPH02235816A (de)
KR (1) KR900013968A (de)
AU (1) AU622989B2 (de)
DE (1) DE69000746T2 (de)
DK (1) DK0386657T3 (de)
IL (1) IL93649A (de)
NZ (1) NZ232782A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393742A (en) * 1990-08-30 1995-02-28 Mect Corporation Preparation for treating renal disease
JPH04112829A (ja) * 1990-08-30 1992-04-14 Mect Corp 腎疾患治療薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2517293B2 (ja) * 1987-06-25 1996-07-24 メクト株式会社 細胞、組織修復剤

Also Published As

Publication number Publication date
IL93649A0 (en) 1990-12-23
AU5116790A (en) 1990-09-13
DK0386657T3 (da) 1993-03-01
IL93649A (en) 1995-03-30
NZ232782A (en) 1997-05-26
KR900013968A (ko) 1990-10-22
EP0386657A1 (de) 1990-09-12
JPH02235816A (ja) 1990-09-18
AU622989B2 (en) 1992-04-30
EP0386657B1 (de) 1993-01-13
DE69000746T2 (de) 1993-05-27

Similar Documents

Publication Publication Date Title
DE68907909D1 (de) Praeparat zur behandlung von erektionsstoerungen.
DE3775597D1 (de) Vorrichtung zur behandlung von teilchenfoermigem material.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE3584013D1 (de) Zubereitung zur behandlung von psoriasis.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE69004501D1 (de) Materialbehandlungsverfahren.
DE59003791D1 (de) Verfahren zur Herstellung von 1,3,3-Trimethyl-5-oxo-cyclohexan-carbonitril.
FI884883A (fi) Ny process.
DE59004274D1 (de) Verfahren zur Herstellung von Alkylhalogensilanen.
DE3681642D1 (de) Benzopyran-verbindungen zur behandlung von inkontinenz.
DE3885460D1 (de) Vorrichtung zur behandlung von flüssigkeiten.
DE3885262D1 (de) Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin.
DE68922714D1 (de) Verfahren zur Herstellung von 2-Phenylbenzotriazolen.
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.
DE58905592D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.
DE69000746D1 (de) Praeparat zur behandlung von systemischem lupus erythomatosus.
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.
DE68903930D1 (de) Lipidemulsion zur behandlung von aids.
DE3670966D1 (de) Vorrichtung zur behandlung granulierten materials.
DE59002525D1 (de) Verfahren zur Herstellung von 2-Chlor-4-nitro-alkylbenzol.
DE59005793D1 (de) Verfahren zur Herstellung von 2-Chlor-5-aminomethylpyridin.
DE69010608D1 (de) Verfahren zur Herstellung von 1,1-Diarylethanen.
DE3579072D1 (de) Vorrichtung zur behandlung von schrammen.
DE68913888D1 (de) Verfahren zur Herstellung von 3,5-dialkyl-4-hydroxybenzyl-substituierten Aromaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee